Rayzebio Inc
(RYZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 251,964 | 33,213 | 129,159 | N/A | N/A |
| Marketable Securities | 288,205 | 223,741 | 167,087 | N/A | N/A |
| TOTAL | $544,986 | $260,546 | $300,037 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 49,696 | 35,321 | 15,084 | N/A | N/A |
| Other Non-Current Assets | 8,831 | 9,895 | 9,655 | 0 | 0 |
| TOTAL | $58,527 | $45,216 | $24,739 | $N/A | $N/A |
| Total Assets | $603,513 | $305,762 | $324,776 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,237 | 2,433 | 2,623 | 0 | 0 |
| Accrued Expenses | 13,610 | 11,000 | 6,691 | N/A | N/A |
| TOTAL | $17,113 | $14,658 | $10,458 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,078 | 426,593 | 425,612 | 0 | 0 |
| TOTAL | $11,078 | $426,593 | $425,612 | $N/A | $N/A |
| Total Liabilities | $28,191 | $441,251 | $436,070 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,920 | 5,243 | N/A | N/A | N/A |
| Common Shares | 6 | 1 | 1 | N/A | N/A |
| Retained earnings | -180,127 | -160,727 | -130,116 | N/A | N/A |
| Other shareholders' equity | -386 | -566 | -553 | 0 | 0 |
| TOTAL | $575,322 | $-135,489 | $-111,294 | $N/A | $N/A |
| Total Liabilities And Equity | $603,513 | $305,762 | $324,776 | $0 | $0 |